Mounjaro scores FDA approval to reduce CV risk; Teva to buy an approved drug

Lilly scores Novo-pressuring Mounjaro expansion to curb heart risks in diabetes patients

In their high-profile competition in the diabetes and obesity markets, Eli Lilly has proven adept at playing catch-up with Novo Nordisk. | In their high-profile competition in the diabetes and obesity markets, Eli Lilly…